In Vitro Antimicrobial Evaluation, Single-Point Resistance Study, and Radiosterilization of Novel Pyrazole Incorporating Thiazol-4-one/Thiophene Derivatives as Dual DNA Gyrase and DHFR Inhibitors against MDR Pathogens
- PMID: 35187315
- PMCID: PMC8851638
- DOI: 10.1021/acsomega.1c05801
In Vitro Antimicrobial Evaluation, Single-Point Resistance Study, and Radiosterilization of Novel Pyrazole Incorporating Thiazol-4-one/Thiophene Derivatives as Dual DNA Gyrase and DHFR Inhibitors against MDR Pathogens
Abstract
A series of thiazol-4-one/thiophene-bearing pyrazole derivatives as pharmacologically attractive cores were initially synthesized using a hybridization approach. All structures were confirmed using spectra analysis techniques (IR, 1H NMR, and 13C NMR). In vitro antimicrobial activities, including the minimum inhibitory concentration (MIC), minimum bactericidal/fungicidal concentration (MBC/MFC), and time-kill assay, were evaluated for the most active derivatives 4a, 5a, 7b, 10, and 13. These derivatives were significantly active against the tested pathogens, with compound 7b as the most active derivative (MIC values range from 0.22 to 0.25 μg/mL). In the MBC and MFC, the active target pyrazole derivatives showed -cidal activities toward the pathogenic isolates. Further, the inhibition of biofilm formation of Staphylococcus aureus and Staphylococcus epidermidis was also carried out. Additionally, these derivatives displayed significant antibiofilm potential with a superior % reduction in the biofilm formation compared with Ciprofloxacin. The target derivatives behaved synergistically with Ciprofloxacin and Ketoconazole, reducing their MICs. Hemolytic results revealed that these derivatives were nontoxic with a significantly low hemolytic activity (%lysis range from 3.23 to 15.22%) compared with Triton X-100 and showed noncytotoxicity activity with IC50 values > 60 μM. In addition, these derivatives proved to be active DNA gyrase and DHFR inhibitors with IC50 ranging between 12.27-31.64 and 0.52-2.67 μM, respectively. Furthermore, compound 7b showed bactericidal activity at different concentrations in the time-kill assay. Moreover, a gamma radiation dose of 10.0 kGy was efficient for sterilizing compound 7b and enhancing its antimicrobial activity. Finally, molecular docking simulation of the most promising derivatives exhibited good binding energy with different interactions.
© 2022 The Authors. Published by American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8851638/bin/ao1c05801_0002.gif)
![Scheme 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8851638/bin/ao1c05801_0009.gif)
![Scheme 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8851638/bin/ao1c05801_0010.gif)
![Scheme 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8851638/bin/ao1c05801_0011.gif)
![Scheme 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8851638/bin/ao1c05801_0012.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8851638/bin/ao1c05801_0003.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8851638/bin/ao1c05801_0004.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8851638/bin/ao1c05801_0005.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8851638/bin/ao1c05801_0006.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8851638/bin/ao1c05801_0007.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8851638/bin/ao1c05801_0008.gif)
Similar articles
-
One-pot synthesis of pyrazolo[4,3-d]thiazole derivatives containing α-aminophosphonate as potential Mur A inhibitors against MDR pathogens with radiosterilization and molecular modeling simulation.RSC Adv. 2023 Nov 29;13(49):34756-34771. doi: 10.1039/d3ra07040a. eCollection 2023 Nov 22. RSC Adv. 2023. PMID: 38035237 Free PMC article.
-
Development and radiosterilization of new hydrazono-quinoline hybrids as DNA gyrase and topoisomerase IV inhibitors: Antimicrobial and hemolytic activities against uropathogenic isolates with molecular docking study.Chem Biol Drug Des. 2023 Feb;101(2):245-270. doi: 10.1111/cbdd.14154. Epub 2022 Oct 28. Chem Biol Drug Des. 2023. PMID: 36305722
-
A new exploration toward adamantane derivatives as potential anti-MDR agents: Design, synthesis, antimicrobial, and radiosterilization activity as potential topoisomerase IV and DNA gyrase inhibitors.Drug Dev Res. 2022 Sep;83(6):1305-1330. doi: 10.1002/ddr.21960. Epub 2022 Jun 18. Drug Dev Res. 2022. PMID: 35716118
-
Hydrazonoyl bromide precursors as DHFR inhibitors for the synthesis of bis-thiazolyl pyrazole derivatives; antimicrobial activities, antibiofilm, and drug combination studies against MRSA.Bioorg Chem. 2021 Nov;116:105339. doi: 10.1016/j.bioorg.2021.105339. Epub 2021 Sep 13. Bioorg Chem. 2021. PMID: 34530234
-
Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.Molecules. 2020 Jun 2;25(11):2593. doi: 10.3390/molecules25112593. Molecules. 2020. PMID: 32498469 Free PMC article.
Cited by
-
Potential anti-amoebic effects of synthetic 1,4-benzothiazine derivatives against Acanthamoeba castellanii.Heliyon. 2023 Dec 10;10(1):e23258. doi: 10.1016/j.heliyon.2023.e23258. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38205285 Free PMC article.
-
Developing a new multi-featured chitosan-quinoline Schiff base with potent antibacterial, antioxidant, and antidiabetic activities: design and molecular modeling simulation.Sci Rep. 2023 Dec 21;13(1):22792. doi: 10.1038/s41598-023-50130-3. Sci Rep. 2023. PMID: 38123716 Free PMC article.
-
One-pot synthesis of pyrazolo[4,3-d]thiazole derivatives containing α-aminophosphonate as potential Mur A inhibitors against MDR pathogens with radiosterilization and molecular modeling simulation.RSC Adv. 2023 Nov 29;13(49):34756-34771. doi: 10.1039/d3ra07040a. eCollection 2023 Nov 22. RSC Adv. 2023. PMID: 38035237 Free PMC article.
-
New Thiophenyl-pyrazolyl-thiazole Hybrids as DHFR Inhibitors: Design, Synthesis, Antimicrobial Evaluation, Molecular Modeling, and Biodistribution Studies.ACS Omega. 2023 Oct 13;8(42):39250-39268. doi: 10.1021/acsomega.3c04736. eCollection 2023 Oct 24. ACS Omega. 2023. PMID: 37901585 Free PMC article.
-
Design, green synthesis, and quorum sensing quenching potential of novel 2-oxo-pyridines containing a thiophene/furan scaffold and targeting a LasR gene on P. aeruginosa.RSC Adv. 2023 Sep 13;13(39):27363-27384. doi: 10.1039/d3ra04230h. eCollection 2023 Sep 8. RSC Adv. 2023. PMID: 37711372 Free PMC article.
References
-
- Park J. Y.; Park S.; Lee S. H.; Lee M. G.; Park Y. B.; Oh K. C.; Lee J.-M.; Kim D. I.; Seo K.-H.; Shin K.-C.; Yoo K. H.; Ko Y.; Jang S. H.; Jung K.-S.; Hwang Y. I. Microorganisms Causing Community-Acquired Acute Bronchitis: The Role of Bacterial Infection. PLoS One 2016, 11, e016555310.1371/journal.pone.0165553. - DOI - PMC - PubMed
-
- Salem M. A.; Ragab A.; Askar A. A.; El-Khalafawy A.; Makhlouf A. H. One-Pot Synthesis and Molecular Docking of Some New Spiropyranindol-2-One Derivatives as Immunomodulatory Agents and in Vitro Antimicrobial Potential with DNA Gyrase Inhibitor. Eur. J. Med. Chem. 2020, 188, 111977.10.1016/j.ejmech.2019.111977. - DOI - PubMed
-
- Administration, U. S. F. and D. Drugs@ FDA : FDA Approved Drug Products; US Food and Drug Administration: Rockville, MD, 2011.
LinkOut - more resources
Full Text Sources